Travoprost is a potent FP receptor agonist that finds clinical use as an ocular hypotensive agent for the treatment of glaucoma. Travoprost is manufactured at Cayman Pharma, our Czech subsidiary. The DMF/ASMF for Travoprost is on file with the US FDA, Canada, India, China, in several EU member states, and in several other countries.